Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 10-2014 | 09-2014 | 07-2014 | 06-2014 | 04-2014 | |
| Sales | 0 | 10 | 0 | 5 | 0 |
| Gross Profit | 10 | 10 | 5 | 5 | 6 |
| Operating Expenses | 0 | 3,578 | 1,490 | 2,441 | 691 |
| Operating Income | N/A | -3,568 | -1,490 | -2,436 | -691 |
| Interest Expense | 0 | 357 | 0 | 83 | 0 |
| Other Income | 0 | -70 | -2,505 | -116 | -1,944 |
| Pre-tax Income | 0 | -3,995 | -3,995 | -2,635 | -2,635 |
| Net Income Continuous | -3,995 | -3,995 | -2,635 | -2,635 | -2,015 |
| Net Income | $-3,995 | $-3,995 | $-3,995 | $-2,635 | $-2,635 |
| EPS Basic Total Ops | N/A | -82.49 | N/A | -59.66 | N/A |
| EPS Basic Continuous Ops | N/A | -82.53 | N/A | -59.67 | N/A |
| EPS Diluted Total Ops | N/A | -82.49 | N/A | -59.66 | N/A |
| EPS Diluted Continuous Ops | N/A | -82.53 | N/A | -59.67 | N/A |
| EBITDA(a) | $N/A | $-3,551 | $-1,520 | $-2,474 | $-699 |